This Bull Market Indicator called NVDA at $116

Every now and again we find an investment idea so incredible we can’t help but share. And today is one of those rare days… Except, today we won't be giving you insight on any one particular stock… But rather, insight on a revolutionary new stock picking indicator… In fact, within the last year, this indicator has become famous for a multitude of reasons… But one of the biggest was because of the buy signal it issued on October 18th, 2022. In fact, on that very day, it said to buy NVDA at $116.37… Anyone who did would be sitting on a tremendously large return today… But even if you missed the original buy signal from October, this incredible indicator issued 11 other buy signals while Nvidia made its epic run…

All you have to do is follow this link here

PROK Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 41.49%

Insider Buying (Last 12 Months): $74,919,037.82

Insider Selling (Last 12 Months): $345,817.61

ProKidney Insider Trading History Chart

ProKidney Share Price & Price History

^$1.65

▼ -0.15 (-8.33%)

As of 11/20/2024 01:00 AM ET

Days: 30 | 90 | 365

[625,000% Gain] – Are You Ready for the Next Altcoin Boom?

From Crypto Swap Profits | Ad

All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you know anything about crypto, you know that altcoin seasons are where some of the biggest gains happen.

ProKidney Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
9/19/2024	Darin J Weber	Insider	Sell	16,412	$2.50	$41,030.00	103,480
7/26/2024	Darin J Weber	Insider	Sell	826	$2.50	$2,065.00	119,892
6/13/2024	Pablo G Legorreta	Director	Buy	22,617,909	$2.42	$54,735,339.78	22,617,909
6/11/2024	Control Empresarial De Capital	Insider	Buy	8,264,462	$2.42	$19,999,998.04	71,560,107
5/20/2024	Darin J Weber	Insider	Sell	17,238	$4.08	$70,331.04	137,956
4/22/2024	Darin J Weber	SVP	Sell	16,438	$2.51	$41,259.38	155,194
4/18/2024	Darin J Weber	SVP	Sell	800	$2.54	$2,032.00	171,632
4/16/2024	Darin J Weber	SVP	Sell	17,238	$2.50	$43,095.00	172,432
4/12/2024	Darin J Weber	SVP	Sell	84,103	$1.73	$145,498.19	189,670
4/1/2024	Darin J Weber	SVP	Sell	300	$1.69	$507.00	273,773
3/25/2024	Control Empresarial De Capital	Insider	Buy	30,000	$1.43	$42,900.00	63,295,645
3/22/2024	Control Empresarial De Capital	Insider	Buy	14,000	$1.40	$19,600.00	63,265,645
3/20/2024	Control Empresarial De Capital	Insider	Buy	33,000	$1.40	$46,200.00	63,251,645
3/13/2024	Control Empresarial De Capital	Insider	Buy	50,000	$1.50	$75,000.00	63,168,645
11/19/2023	Chamath Palihapitiya	Major Shareholder	Sell	7,256,367	$1.31	$9,505,840.77
11/17/2023	Chamath Palihapitiya	Major Shareholder	Sell	258,400	$1.19	$307,496.00	5,183,367
11/15/2023	Chamath Palihapitiya	Major Shareholder	Sell	282,300	$1.49	$420,627.00	5,653,867
11/13/2023	Chamath Palihapitiya	Major Shareholder	Sell	88,700	$1.57	$139,259.00	6,242,367
11/10/2023	Chamath Palihapitiya	Major Shareholder	Sell	85,900	$1.61	$138,299.00	6,331,067
11/8/2023	Chamath Palihapitiya	Major Shareholder	Sell	59,000	$1.66	$97,940.00	6,512,867
11/6/2023	Chamath Palihapitiya	Major Shareholder	Sell	79,600	$1.56	$124,176.00	6,643,100
11/3/2023	Chamath Palihapitiya	Major Shareholder	Sell	148,300	$1.73	$256,559.00	6,722,700
11/1/2023	Chamath Palihapitiya	Major Shareholder	Sell	123,400	$1.62	$199,908.00	7,004,700
10/30/2023	Chamath Palihapitiya	Major Shareholder	Sell	157,000	$1.65	$259,050.00	7,270,000
10/27/2023	Chamath Palihapitiya	Major Shareholder	Sell	92,500	$1.59	$147,075.00	7,427,000
10/25/2023	Chamath Palihapitiya	Major Shareholder	Sell	67,213	$1.76	$118,294.88	7,597,460
10/23/2023	Chamath Palihapitiya	Major Shareholder	Sell	160,300	$1.83	$293,349.00	7,840,973
10/20/2023	Chamath Palihapitiya	Major Shareholder	Sell	87,200	$1.92	$167,424.00	8,001,273
10/18/2023	Chamath Palihapitiya	Major Shareholder	Sell	125,100	$2.28	$285,228.00	8,288,473
10/16/2023	Chamath Palihapitiya	Major Shareholder	Sell	215,543	$2.87	$618,608.41	8,519,973
10/12/2023	Chamath Palihapitiya	Major Shareholder	Sell	161,863	$2.69	$435,411.47	8,985,516
10/9/2023	Chamath Palihapitiya	Major Shareholder	Sell	75,000	$4.20	$315,000.00	9,297,379
10/5/2023	Chamath Palihapitiya	Major Shareholder	Sell	52,621	$4.76	$250,475.96	9,447,379
9/19/2023	Chamath Palihapitiya	Major Shareholder	Sell	1,700,000	$5.47	$9,299,000.00	2,073,000

[625,000% Gain] – Are You Ready for the Next Altcoin Boom?

From Crypto Swap Profits | Ad

SEC Filings (Institutional Ownership Changes) for ProKidney (NASDAQ:PROK)

51.59% of ProKidney stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

ProKidney Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
11/19/2024	Barclays PLC	146,321	$0.28M	0.0%	+575.7%	0.051%
11/16/2024	Geode Capital Management LLC	2,203,934	$4.23M	0.0%	+102.0%	0.761%
11/15/2024	Barclays PLC	146,321	$0.28M	0.0%	+575.7%	0.051%
11/15/2024	XTX Topco Ltd	21,267	$41K	0.0%	N/A	0.007%
11/15/2024	Jane Street Group LLC	40,530	$78K	0.0%	-14.6%	0.014%
11/15/2024	State Street Corp	1,428,318	$2.74M	0.0%	+16.2%	0.493%
11/14/2024	Suvretta Capital Management LLC	12,341,266	$23.70M	0.8%	+32.1%	4.260%
11/14/2024	MetLife Investment Management LLC	62,660	$0.12M	0.0%	+90.6%	0.022%
11/13/2024	The Manufacturers Life Insurance Company	37,981	$73K	0.0%	+54.6%	0.013%
11/12/2024	Charles Schwab Investment Management Inc.	749,718	$1.44M	0.0%	+150.6%	0.259%
11/9/2024	Intech Investment Management LLC	24,075	$46K	0.0%	N/A	0.008%
10/21/2024	Castleview Partners LLC	32,921	$63K	0.0%	N/A	0.014%
8/15/2024	Susquehanna Fundamental Investments LLC	42,990	$0.11M	0.0%	N/A	0.019%
8/15/2024	The Manufacturers Life Insurance Company	24,566	$60K	0.0%	N/A	0.011%
8/15/2024	AQR Capital Management LLC	20,518	$50K	0.0%	N/A	0.009%
8/14/2024	Marshall Wace LLP	50,242	$0.12M	0.0%	N/A	0.022%
8/8/2024	Federated Hermes Inc.	23,303	$57K	0.0%	-79.4%	0.010%
8/1/2024	Rhumbline Advisers	76,190	$0.19M	0.0%	+8.8%	0.033%
7/26/2024	Bank of New York Mellon Corp	179,236	$0.44M	0.0%	+44.6%	0.078%
5/10/2024	Vanguard Group Inc.	1,813,079	$2.97M	0.0%	-37.5%	0.791%
4/24/2024	Zullo Investment Group Inc.	19,420	$32K	0.0%	N/A	0.008%
2/7/2024	Jump Financial LLC	21,677	$39K	0.0%	-54.0%	0.009%
1/31/2024	Federated Hermes Inc.	113,286	$0.20M	0.0%	+10,984.7%	0.048%
1/12/2024	SG Americas Securities LLC	46,829	$83K	0.0%	+174.2%	0.020%
11/7/2023	New York State Common Retirement Fund	17,274	$79K	0.0%	-30.1%	0.007%
11/7/2023	Jump Financial LLC	47,100	$0.22M	0.0%	N/A	0.020%
10/27/2023	Social Capital Group LLC	11,573,000	$53M	89.0%	-12.8%	4.922%
10/24/2023	Bank of New York Mellon Corp	127,956	$0.59M	0.0%	-21.9%	0.054%
10/13/2023	SG Americas Securities LLC	17,080	$78K	0.0%	N/A	0.007%
8/10/2023	Letko Brosseau & Associates Inc.	15,900	$0.18M	0.0%	N/A	0.007%
8/10/2023	Metropolitan Life Insurance Co NY	3,429	$38K	0.0%	N/A	0.001%
8/4/2023	American International Group Inc.	29,698	$0.33M	0.0%	N/A	0.013%
8/3/2023	Bank of New York Mellon Corp	163,811	$1.83M	0.0%	N/A	0.070%
7/31/2023	Strs Ohio	12,800	$0.14M	0.0%	N/A	0.005%
7/19/2023	Salem Investment Counselors Inc.	3,000	$34K	0.0%	+547.9%	0.001%
2/13/2023	Social Capital Group LLC	13,273,000	$91.05M	77.7%	N/A	51.767%
2/8/2023	Swiss National Bank	74,301	$0.51M	0.0%	N/A	0.290%
1/24/2023	Brown University	1,000,000	$6.86M	2.9%	N/A	3.900%
11/15/2022	Bleichroeder LP	2,000,000	$18.02M	3.8%	N/A	7.800%
11/14/2022	Verition Fund Management LLC	14,603	$0.13M	0.0%	N/A	0.057%
11/14/2022	Moore Capital Management LP	26,500	$0.24M	0.0%	N/A	0.103%

Data available starting January 2016

ProKidney Corp., a clinical-stage biotechnology company, provides transformative proprietary cell therapy platform for treating various chronic kidney diseases in the United States. The company's lead product is Renal Autologous Cell Therapy (REACT), an autologous homologous cell admixture, which has completed Phase I clinical trial for REACT in patients with congenital anomalies of the Kidney and Urinary Tract (CAKUT), as well as in Phase III and Phase II clinical trials for the treatment of moderate to severe diabetic kidney disease. ProKidney Corp. founded in 2015 and is headquartered in Winston-Salem, North Carolina.

Today's Range

Now: $1.65

$1.62

$1.81

50 Day Range

MA: $1.90

$1.55

$2.46

52 Week Range

Now: $1.65

$1.18

$4.44

Volume

329,693 shs

Average Volume

707,620 shs

Market Capitalization

$477.96 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.11

Who are the company insiders with the largest holdings of ProKidney?: ProKidney's top insider shareholders include:
Control Empresarial De Capital (Insider)
Pablo G Legorreta (Director)
Chamath Palihapitiya (Major Shareholder)
Darin J Weber (SVP)
Darin J Weber (Insider)
Learn More about top insider investors at ProKidney.
Who are the major institutional investors of ProKidney?: ProKidney's top institutional shareholders include:
Suvretta Capital Management LLC — 4.26%
Geode Capital Management LLC — 0.76%
State Street Corp — 0.49%
Charles Schwab Investment Management Inc. — 0.26%
Barclays PLC — 0.05%
Barclays PLC — 0.05%
Learn More about top institutional investors of ProKidney stock.
Which major investors are selling ProKidney stock?: In the previous quarter, PROK stock was sold by these institutional investors:
Jane Street Group LLC
During the last year, company insiders that have sold ProKidney company stock include:
Control Empresarial De Capital (Insider)
Pablo G Legorreta (Director)
Learn More investors selling ProKidney stock.
Which major investors are buying ProKidney stock?: In the previous quarter, PROK stock was purchased by institutional investors including:
Suvretta Capital Management LLC
Geode Capital Management LLC
Charles Schwab Investment Management Inc.
State Street Corp
Barclays PLC
Barclays PLC
Castleview Partners LLC
MetLife Investment Management LLC
During the previous year, these company insiders have bought ProKidney stock:
Control Empresarial De Capital (Insider)
Pablo G Legorreta (Director)
Learn More investors buying ProKidney stock.